SAUDI LYMPHOMA/MYELOMA AND HEMATOPATOLOGY OVERVIEW 2024
OBJECTIVES
The objectives of this conference are as follows
WHO SHOULD ATTEND?
This educational program is intended for Hematologists, Hemato-Pathologists, Medical Oncologists, Radiation Oncologists, Nuclear Medicine Specialists, Fellows and Residents in Training, Lab Scientists, Lab Technicians and technologists, and other healthcare providers who are involved in and/or interested in hematological disorders and SCT. State of the art lectures, evidence-based hematology sessions, and satellite symposia covering the latest technological developments will be the main features of the program.
Thank you to everyone who took part in Saudi Lymphoma/Myeloma 2024 Hematopathology Overview 2024.
This event has already taken place. View the highlights in our gallery, or contact us about upcoming events.